Author

Leslie Jacobs

Observed name: L. Jacobs

Institution: C2N Diagnostics (United States)

Observed institutions: Centre for Addiction and Mental Health, University of Toronto, C2N Diagnostics (United States), START Clinic

ORCID: 0000-0001-6944-5145

Observed ORCID: 0000-0001-6944-5145

OpenAlex ID: A5073748877

Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trial

2008 · M.A. Katzman, M. Vermani, et al. · Journal of Anxiety Disorders · 61

Did a switch to a generic antidepressant cause relapse?

2008 · Jessica Rosenthal, Brian Kong, et al. · PubMed · 17

Venlafaxine in the treatment of panic disorder

2007 · Martin A Katzman, Leslie Jacobs · Neuropsychiatric Disease and Treatment · 17

Weight gain and psychiatric treatment: is there as role for green tea and conjugated linoleic acid?

2007 · Martin A Katzman, Leslie Jacobs, et al. · Lipids in Health and Disease · 16

Clinical Utility of an Alzheimer’s Disease Blood Test Among Cognitively Impaired Patients: Results from the Quality Improvement PrecivityAD2 (QUIP II) Clinician Survey Study

2025 · Mark Monane, Demetrius M. Maraganore, et al. · Diagnostics · 11

Beyond shy: when to suspect social anxiety disorder.

2007 · Jessica Rosenthal, Leslie Jacobs, et al. · PubMed · 8

P.1.e.010 Understanding postpartum blues: a time course of MAO-A levels in the living human brain during the postpartum period

2009 · J. Sacher, A.A. Wilson, et al. · European Neuropsychopharmacology · 1

P.8.a.017 A flexible dose open label trial evaluating the efficacy and safety of quetiapine as adjunctive pharmacotherapy for the treatment of generalized anxiety disorder (GAD)

2006 · M.A. Katzman, M. Vermani, et al. · European Neuropsychopharmacology · 1

The Effect of Patient Age and Sex on Decision-Making Around An Alzheimer’s Disease Blood Test: QUIP II Study Results

2025 · Mark Monane, Kim Johnson, et al. · Innovation in Aging

Implementation of an Alzheimer’s Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study

2025 · Mark Monane, Robert M. Carlile, et al. · Journal of Personalized Medicine

Early Clinical Utility Data of a Multi-analyte Blood Biomarker Test for Evaluating Cognitive Impairment

2024 · Mark Monane, David Merrill, et al. · Innovation in Aging

Early Clinical Utility Data of a Multi-analyte Blood Biomarker Test for Evaluating Cognitive Impairment

2024 · Mark Monane, David Merrill, et al. · Innovation in Aging

Implementation Study of the Use of a Blood Biomarker Test in Alzheimer’s Disease: Clinician Survey From Quip Ii Study

2024 · Mark Monane, Robert Carlile, et al. · Innovation in Aging

MAO-A: A core neurochemical imaging biomarker for postpartum depression (PPD) and populations at risk for PPD

2014 · Julia Sacher, P. Vivien Rekkas, et al. · Max Planck Digital Library

Monoamine oxidase A (MAO-A)binding in prefrontal and anterior cingulate cortex in postpartum depression

2011 · Julia Sacher, Alan A. Wilson, et al. · Max Planck Digital Library

Works count: 15

Citation count: 132

H-index: 6

I10-index: 5